NextPlat (NXPL) Total Non-Current Liabilities (2011 - 2019)
NextPlat's (NXPL) quarterly Total Non-Current Liabilities came in at $1.2 million in Q1 2019, up 15.94% quarter-over-quarter from $1.1 million in Q4 2018.
Analysis
NextPlat (NXPL) Total Non-Current Liabilities (2011 - 2019) Analysis & Trends
NextPlat (NXPL) has reported Total Non-Current Liabilities for 7 consecutive years, with $1.2 million the latest figure, recorded in Q1 2019.
- On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $1.2 million in Q1 2019; TTM through Mar 2019 was $1.2 million, a N/A change from a year earlier, with the FY2018 full-year figure at $1.1 million, down 12.14% from the prior year.
- Total Non-Current Liabilities was $1.2 million for Q1 2019 at NextPlat, up from $1.1 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $1.3 million in Q3 2017 and troughed at -$750.1 million in Q1 2016.
- A 5-year average of -$135.5 million and a median of $1.1 million in 2018 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities tumbled 36.18% in 2016 and jumped 100.14% in 2017, its largest moves.
- Over 5 years, Total Non-Current Liabilities stood at $1.1 million in 2015, then plunged by 36.18% to $719380.0 in 2016, then jumped by 67.13% to $1.2 million in 2017, then fell by 12.14% to $1.1 million in 2018, then climbed by 15.94% to $1.2 million in 2019.
- The last three Total Non-Current Liabilities figures came in at $1.2 million (Q1 2019), $1.1 million (Q4 2018), and $1.2 million (Q4 2017), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 16.45 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 18.76 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 1.29 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 2.78 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 24.86 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 881.37 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 1.45 Bn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 946.17 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 20.92 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 1.22 Mn |
| Dec 31, 2018 | 1.06 Mn |
| Dec 31, 2017 | 1.20 Mn |
| Sep 30, 2017 | 1.29 Mn |
| Jun 30, 2017 | 1.07 Mn |
| Mar 31, 2017 | 1.04 Mn |
| Dec 31, 2016 | 719,380.00 |
| Sep 30, 2016 | 966,031.00 |
| Jun 30, 2016 | -750.00 Mn |
| Mar 31, 2016 | -750.11 Mn |
| Dec 31, 2015 | 1.13 Mn |
| Dec 31, 2012 | 1.66 Mn |
| Sep 30, 2012 | 1.48 Mn |
| Jun 30, 2012 | 1.14 Mn |
| Dec 31, 2011 | 688,764.00 |